Matthias Schwab

40PUBLICATIONS
234CO-AUTHORS
BiomaterialsPharmacogenomicsGene and molecular therapyMolecular targetsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Sep 11, 2026
The FAP × CD3 bispecific antibody OMTX305 induces T cell-mediated antitumor effects in patient-derived ex vivo models of solid tumors.

|Aug 06, 2026
Clinical Functional Assignment of TPMT and NUDT15 Alleles by the Clinical Pharmacogenetics Implementation Consortium Pharmacogene Curation Expert Panel.

|Jul 02, 2026
Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

|Jun 15, 2026
Targeting ACKR3/CXCR7 enhances platelet anticoagulant acylcarnitines and modulates procoagulant function.

|Apr 14, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.

Claire Moore, Melissa S Bourque, Andreas Halman

|Jan 31, 2026
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update.

Maud Maillard, Matthias Schwab, Michelle Whirl-Carrillo

Pageof 7

Frequent Collaborators

7 joint publications

Thorsten Lehr

7 joint publications

Roman Tremmel

6 joint publications

Hiltrud Brauch

5 joint publications

Thomas E Mürdter